Smad4/DPC4: A barrier against tumor progression driven by RTK/Ras/Erk and Wnt/GSK3 signaling.
Ontology highlight
ABSTRACT: The tumor suppressor Smad4/DPC4 is an essential transcription factor in the TGF-β pathway that was previously thought to function constitutively. We recently reported that Smad4 activity and stability are directly regulated by 2 major signaling pathways, RTK/MAPK and Wnt/GSK3. Here we examine the molecular, cellular, and potential therapeutic significance of these findings.
SUBMITTER: Demagny H
PROVIDER: S-EPMC4905428 | biostudies-other | 2016 Mar
REPOSITORIES: biostudies-other
ACCESS DATA
